article thumbnail

AI use in repurposing drugs for Covid-19

Drug Discovery World

We screen cells that have been altered by hundreds of thousands of different chemical and genetic factors to represent different states of healthy, sick and treated cells, while our ML algorithms analyse the resulting millions of images to predict relationships across biological contexts and chemical factors.

Drugs 59
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

article thumbnail

Re-assessing the risks of drug-induced arrhythmias during drug discovery

Drug Discovery World

We suggest a new generation of screening assays, that better recapitulate the electrophysiology of the whole human heart, may allow better decisions across research and development. The models chosen can be surprisingly ‘under-evaluated’ given their powerful effect on the quality of research and development decisions.

Drugs 52